# OnCo record paper-bonner-cetuximab-radiotherapy-nejm-2006 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-bonner-cetuximab-radiotherapy-nejm-2006/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-bonner-cetuximab-radiotherapy-nejm-2006" ;
  schema:name "Radiotherapy plus cetuximab for locoregionally advanced squamous cell carcinoma of the head and neck"@en ;
  schema:description "Adding the EGFR antibody cetuximab to radiotherapy lengthened survival in locally advanced head and neck cancer by about 20 months without increasing the mucosal toxicity of radiotherapy, giving patients unfit for cisplatin an alternative."@en ;
  schema:url <https://onco.cc/key-papers/paper-bonner-cetuximab-radiotherapy-nejm-2006/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://doi.org/10.1056/NEJMoa053422>, <https://pubmed.ncbi.nlm.nih.gov/16467544/> ;
  schema:sameAs <https://doi.org/10.1056/NEJMoa053422> ;
  schema:datePublished "2006"^^xsd:gYear ;
  schema:author "Bonner JA, Harari PM, Giralt J, et al." ;
  onco:cancers <https://onco.cc/cancers/hpv-negative-head-and-neck-cancer/>, <https://onco.cc/cancers/hypopharyngeal-cancer/>, <https://onco.cc/cancers/lip-cancer/> ;
  onco:drugs <https://onco.cc/drugs/cetuximab/> ;
  onco:journals <https://onco.cc/journals/nejm/> .
